[Skip to content]

Friday 19 April 2019
Derbyshire Healthcare NHS Foundation Trust
Search our Site

Pople living with psychosis invited to take part in national research study

Prevalence of Pathogenic Antibodies in Psychosis (PPiP) study

Emerging research suggests that some cases of psychosis are caused by an autoimmune disorder where the body produces antibodies which attack our own brain cells. 

To identify the prevalence of these antibodies in patients, the Trust’s research team is playing a pivotal role in a national study that has attracted significant media and scientific interest of late – the Prevalence of Pathogenic Antibodies in Psychosis (PPiP) study. Our health researchers are aiming to recruit 80 Derbyshire Healthcare patients with psychosis to participate in the study by to providing a sample of blood. 

If you're interested in taking part and meet the inclusion criteria, please get in touch with the Research Team on the contact details below. 

Researchers can provide anyone interested with all the information needed to make an informed choice. The whole process takes about 15 minutes and participants will receive £10 as appreciation for their time.

Inclusion criteria

Exclusion criteria

Age 18 - 70

Primary drug-induced psychosis (concurrent drug use is OK)

Acute psychotic symptoms lasting more than 2 weeks but no longer than 2 years

Any other neurological disorder including multiple sclerosis, epilepsy, cerebrovascular disease, hydrocephalus, traumatic brain injury, meningo-encephalitis, systemic lupus erythematosus, CNS vasculitis.

For further information, please email dhcft.research@nhs.net or call 01332 623700 ext 33650.